[Form 4] Erie Indemnity Co Insider Trading Activity

Rhea-AI Filing Summary

Life360, Inc. (Form 144) – Director-level insider Lauren Antonoff has filed notice to sell 4,546 common shares through Fidelity Brokerage on or about 24 Jul 2025. At the referenced market price, the proposed sale equals $344,087 and represents <0.01 % of the roughly 76.5 million shares outstanding, indicating limited direct dilution or float impact.

The shares to be sold were acquired via restricted-stock vesting on 20 Jun 2024. The filing also discloses a recent selling pattern: between 24 Apr 2025 and 24 Jun 2025 Antonoff disposed of 32,446 shares for total gross proceeds of $1.96 million. No additional financial or operational data accompany the notice, and the signer represents no knowledge of undisclosed adverse information.

Form 144 is only a pre-trade notification; execution remains subject to Rule 144 volume, timing and manner-of-sale conditions. While serial insider sales can weigh on sentiment, the absolute size is immaterial to Life360’s capital structure, so the filing is unlikely to move fundamentals absent broader context.

Insights

Equity Analyst

TL;DR: Small insider sale; negligible fundamental impact but may add modest negative sentiment.

At <0.01 % of outstanding shares, the $344 k planned sale barely dents float and should not affect liquidity or earnings per share. The seller’s prior $1.96 m disposals over three months suggest a 10b5-1-style program rather than a one-off liquidity event, limiting information value. Given the absence of operational disclosures, I view the filing as neutral for valuation; investors may monitor for pattern acceleration.

Corporate Governance Specialist

TL;DR: Continued insider selling could flag governance-related perception risks.

Although quantitatively minor, repeat sales within a short window can erode investor confidence, especially if no offsetting insider purchases occur. Lack of a disclosed 10b5-1 adoption date removes automatic-trading safe-harbor transparency. I assign a slightly negative governance signal, but do not expect material price pressure absent larger volumes or additional insiders joining the trend.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

HARTZ CHARLES SCOTT

(Last) (First) (Middle)

THE HARTZ GROUP

TWO BALA PLAZA, SUITE 300

(Street)

BALA CYNWYD PA 19004

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ERIE INDEMNITY CO [ ERIE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/22/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock								1,097.427	I	By C. Scott Hartz 2005 Delaware Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Directors' Deferred Compensation Share Credits	$0(1)	07/22/2025		J(2)		71.036		(3)	(3)	Class A Common Stock	71.036	$364.1	18,861.274	D

Explanation of Responses:

1. Conversion price is not applicable to shares granted under the Outside Directors' Deferred Compensation Plan.

2. Acquired under dividend reinvestment for Directors' Deferred Compensation Plan.

3. The shares subject to this reporting are Share Credits which are periodically credited to the accounts of certain Directors of Erie Indemnity Company pursuant to its Outside Directors' Stock Plan. These Share Credits represent the right to receive an equivalent number of shares of Erie Indemnity Company Class A common stock when the reporting individual's service as a Director of the Company ends. There are no exercisable or expiration dates for these securities.

Remarks:

	Rebecca A. Buona, Power of Attorney	07/24/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.